Skip to main content

Main navigation

  • About
    • Members
    • Staff
    • Annual Report
    • Health Policy Fellowship
    • Contact Us
  • Topics
    • Health Spending
      • Understanding Health Spending
      • Low-Value Care
      • Health Spend Management
      • 340B Drug Pricing Program
    • Value Assessment
      • Value Assessment Frameworks
      • Value Assessment Methods
      • Elements of Value
    • Alternative Payment Models
      • Value-Based Contracts
      • Regulatory Barriers & Challenges
      • Paying for Cures
      • Accountable Care Organizations
      • Bundled Payments
      • Health Care Quality Measures
      • Clinical Pathways
    • Patient Centered Formulary & Benefit Design
      • High-Deductible Health Plans
      • Value-Based Insurance Design
      • Utilization Management & Step Therapy
      • Formulary Development
      • Patient Cost Sharing
      • Individual Treatment Effects & Personalized Access
    • Evidence for Decision Making
      • Real-World Data
      • Real-World Evidence
      • Good Practices for Evidence
    • Biopharma Innovation
      • Impact on Outcomes & Spending
  • Resources
    • Research
    • Letters & Comments
    • E.V.I.dently Today Blog
    • Events
    • CER Daily Newsfeed®
    • E.V.I.dently® Newsletter
    • Videos and Graphics
    • Press Room
      • NPC in the News
    • Stakeholder Resources
      • For Employers
      • For Patient Organizations
      • Going Below The Surface
  • Get Involved
    • Become a Member
    • Submit a Research Proposal
    • Start a Career
National Pharmaceutical Council

Offscreen menu

User account menu

  • Member Resources

Continuing Innovation for Rare Conditions Under the Orphan Drug Act 

  • Read more about Continuing Innovation for Rare Conditions Under the Orphan Drug Act 

Innovation Matters: Changing Lives for Cystic Fibrosis Patients

  • Read more about Innovation Matters: Changing Lives for Cystic Fibrosis Patients

Innovation Matters: The Evolution of Cancer Therapies

  • Read more about Innovation Matters: The Evolution of Cancer Therapies

Innovation Matters: The Unintended Consequences of Drug Pricing Regulation

  • Read more about Innovation Matters: The Unintended Consequences of Drug Pricing Regulation

Innovation Matters: Building a Healthier World

  • Read more about Innovation Matters: Building a Healthier World

Innovating to Help Patients with Rare Diseases

  • Read more about Innovating to Help Patients with Rare Diseases

Innovation Matters: Revolutionary Changes for Arthritis Patients

  • Read more about Innovation Matters: Revolutionary Changes for Arthritis Patients

What If Groundbreaking Medicines Never Existed?

  • Read more about What If Groundbreaking Medicines Never Existed?

What Might Have Happened: The Impact of Interrupting Entry of Innovative Drugs on Disease Outcomes in the United States

  • Read more about What Might Have Happened: The Impact of Interrupting Entry of Innovative Drugs on Disease Outcomes in the United States

At the Heart of It: How Innovation Drives Improved Patient Outcomes

  • Read more about At the Heart of It: How Innovation Drives Improved Patient Outcomes

Pagination

  • Page 1
  • Next page
Subscribe to Biopharmaceutical Innovation

Let's stay in touch.

Subscribe to Our Newsletter
© 2021 NPC. All rights reserved.

Footer Menu

  • Accessibility
  • Privacy Policy
  • Terms of Use
  • Contact Us

Footer Social Links Menu

  • Twitter
  • Linkedin
  • Youtube